Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: A meta-analysis

Irish Journal of Medical Science

Volumn 183, Issue 2, 2014, Pages 283-291

  Chen, W ^a   Li, F ^a   He, C ^a   Zhu, Y ^a   Tan, W ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Abnormal glucose metabolism; Metaanalysis; Metabolic disease; Primary aldosteronism

Indexed keywords

BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84905159110     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-1007-x     Document Type: Article

References (35)

1. Conn JW (1965) Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 273(21):1135-1143
2. Fallo F, Veglio F, Bertello C et al (2006) Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91(2):454-459 (Pubitemid 43236909)
3. Connell JM, MacKenzie SM, Freel EM et al (2008) A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-154 (Pubitemid 351519688)
4. Quinkler M, Born-Frontsberg E, Fourkiotis VG (2010) Comorbidities in primary aldosteronism. Horm Metab Res 42(6):429-434
5. Strauch B, Widimsky J, Sindelka G et al (2003) Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol Res 52(4):503-506 (Pubitemid 37039916)
6. Colussi G, Catena C, Lapenna R et al (2007) Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 30(9):2349-2354 (Pubitemid 47359046)
7. Giacchetti G, Ronconi V, Turchi F et al (2007) Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25(1):177-186 (Pubitemid 44885680)
8. Kreze AS, Kreze-Spirova E, Mikulecky M (2000) Diabetes mellitus in primary aldosteronism. Bratisl Lek Listy 101(4):187-190
9. Choi CS, Thompson CB, Leong PK et al (2001) Short-term K(+) deprivation provokes insulin resistance of cellular K(+) uptake revealed with the K(+) clamp. Am J Physiol Renal Physiol 280(1):F95-F102
10. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008-2012 (Pubitemid 30214957)
11. Singer S, Das-Munshi J, Brahler E (2010) Prevalence of mental health conditions in cancer patients in acute care-a meta-analysis. Ann Oncol 21(5):925-930
12. Biddle DA, Morris SB (2011) Using Lancaster's mid-P correction to the Fisher's exact test for adverse impact analyses. J Appl Psychol 96(5):956-965
13. Lydersen S, Laake P (2003) Power comparison of two-sided exact tests for association in 2 x 2 contingency tables using standard, mid p and randomized test versions. Stat Med 22(24):3859-3871 (Pubitemid 38008705)
14. Brown L, Cai T, DasGupta A (2001) Interval estimation for a binomial proportion. Stat Sci 16:101-117
15. Higgins JP, Green S, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, in http://www.cochrane-handbook.org/
16. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109): 629-634 (Pubitemid 27387172)
17. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088-1101
18. Catena C, Lapenna R, Baroselli S et al (2006) Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 91(9):3457-3463 (Pubitemid 44402119)
19. Fallo F, Della Mea P, Sonino N et al (2007) Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 20(8):855-861 (Pubitemid 47176347)
20. Haluzik M, Sindelka G, Widimsky J Jr et al (2002) Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 16(1):41-45 (Pubitemid 34134092)
21. Iacobellis G, Petramala L, Cotesta D et al (2010) Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab 95(5):2391-2398
22. Ishimori M, Takeda N, Okumura S et al (1994) Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol (Oxf) 41(4):433-438 (Pubitemid 24301275)
23. Matrozova J, Steichen O, Amar L et al (2009) Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53(4):605-610
24. Mosso LM, Carvajal CA, Maiz A et al (2007) A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 25(10):2125-2130 (Pubitemid 47476311)
25. Reincke M, Meisinger C, Holle R et al (2010) Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res 42(6):435-439
26. Widimsky J Jr, Sindelka G, Haas T et al (2000) Impaired insulin action in primary hyperaldosteronism. Physiol Res 49(2):241-244 (Pubitemid 30365884)
27. Widimsky J Jr, Strauch B, Sindelka G et al (2001) Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol Res 50(6):603-607 (Pubitemid 34087280)
28. Sindelka G, Widimsky J, Haas T et al (2000) Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabet 108(1):21-25 (Pubitemid 30160431)
29. Fischer E, Adolf C, Pallauf A et al. (2013) Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrin Metab 98(6):2513-2520
30. Nanba K, Tamanaha T, Nakao K et al (2012) Confirmatory testing in primary aldosteronism. J Clin Endocrinol Metab 97(5):1688-1694
31. Reungjui S, Pratipanawatr T, Johnson RJ et al (2008) Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens 17(5):470-476
32. Yokoshiki H, Sunagawa M, Seki T et al (1998) ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 274(1 Pt 1):C25-C37
33. Fallo F, Pilon C, Urbanet R (2012) Primary aldosteronism and metabolic syndrome. Horm Metab Res 44(3):208-214
34. Underwood PC, Adler GK (2013) The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 15(1):59-70
35. Vaidya A, Underwood PC, Hopkins PN et al (2013) Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension 61(4):886-893